4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
61388963
Academy of Sciences of the Czech Republic
FISR2019_04819
Italian Ministry of Education, University and Research
PRIN 201744BN5T
Italian Ministry of Education, University and Research
PubMed
34592052
PubMed Central
PMC9298201
DOI
10.1002/cmdc.202100510
Knihovny.cz E-zdroje
- Klíčová slova
- Bacterial carbonic anhydrases, Drug Discovery, Enzymes Inhibitors, Sulfonamides, Vibrio cholerae,
- MeSH
- benzensulfonamidy MeSH
- inhibitory karboanhydras chemická syntéza chemie farmakologie MeSH
- karboanhydrasy genetika metabolismus MeSH
- lidé MeSH
- molekulární modely MeSH
- molekulární struktura MeSH
- sulfonamidy chemická syntéza chemie farmakologie MeSH
- Vibrio cholerae účinky léků genetika MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- inhibitory karboanhydras MeSH
- karboanhydrasy MeSH
- sulfonamidy MeSH
A current issue of antimicrobial therapy is the resistance to treatment with worldwide consequences. Thus, the identification of innovative targets is an intriguing challenge in the drug and development process aimed at newer antimicrobial agents. The state-of-art of anticholera therapy might comprise the reduction of the expression of cholera toxin, which could be reached through the inhibition of carbonic anhydrases expressed in Vibrio cholerae (VchCAα, VchCAβ, and VchCAγ). Therefore, we focused our interest on the exploitation of sulfonamides as VchCA inhibitors. We planned to design and synthesize new benzenesulfonamides based on our knowledge of the VchCA catalytic site. The synthesized compounds were tested thus collecting useful SAR information. From our investigation, we identified new potent VchCA inhibitors, some of them displayed high affinity toward VchCAγ class, for which few inhibitors are currently reported in literature. The best interesting VchCAγ inhibitor (S)-N-(1-oxo-1-((4-sulfamoylbenzyl)amino)propan-2-yl)furan-2-carboxamide (40) resulted more active and selective inhibitor when compared with acetazolamide (AAZ) as well as previously reported VchCA inhibitors.
CHIBIOFARAM Department University of Messina Viale Stagno D'Alcontres 98166 Messina Italy
Institute of Biosciences and Bioresources CNR Via Castellino 111 80131 Napoli Italy
NEUROFARBA Department University of Florence Via U Schiff 6 50019 Florence Italy
Zobrazit více v PubMed
Ramamurthy T., Mutreja A., Weill F. X., Das B., Ghosh A., Nair G. B., Front Public Health 2019, 7, 203. PubMed PMC
Weil A. A., Ryan E. T., Curr. Opin. Infect. Dis. 2018, 31, 455–461. PubMed
Abuaita B. H., Withey J. H., Infect. Immun. 2009, 77, 4111–4120. PubMed PMC
Supuran C. T., Expert Opin. Ther. Pat. 2018, 28, 709–712. PubMed
Capasso C., Supuran C. T., Expert Opin. Ther. Targets 2015, 19, 1689–1704. PubMed
Ferraroni M., Del Prete S., Vullo D., Capasso C., Supuran C. T., Acta Crystallogr. Sect. D 2015, 71, 2449–2456. PubMed
Del Prete S., Isik S., Vullo D., De Luca V., Carginale V., Scozzafava A., Supuran C. T., Capasso C., J. Med. Chem. 2012, 55, 10742–10748. PubMed
Park H. M., Park J. H., Choi J. W., Lee J., Kim B. Y., Jung C. H., Kim J. S., Acta Crystallogr. Sect. D 2012, 68, 920–926. PubMed
Del Prete S., Vullo D., De Luca V., Carginale V., Osman S. M., AlOthman Z., Supuran C. T., Capasso C., Bioorg. Med. Chem. Lett. 2016, 26, 1941–1946. PubMed
Del Prete S., Vullo D., De Luca V., Carginale V., di Fonzo P., Osman S. M., AlOthman Z., Supuran C. T., Capasso C., Bioorg. Med. Chem. 2016, 24, 3413–3417. PubMed
Capasso C., Supuran C. T., Expert Opin. Ther. Pat. 2013, 23, 693–704. PubMed
Akgul O., Angeli A., Selleri S., Capasso C., Supuran C. T., Carta F., Eur. J. Med. Chem. 2021, 219, 113444. PubMed
Mancuso F., Di Fiore A., De Luca L., Angeli A., Monti S. M., De Simone G., Supuran C. T., Gitto R., ACS Med. Chem. Lett. 2020, 11, 1000–1005. PubMed PMC
Buemi M. R., Di Fiore A., De Luca L., Angeli A., Mancuso F., Ferro S., Monti S. M., Buonanno M., Russo E., De Sarro G., De Simone G., Supuran C. T., Gitto R., Eur. J. Med. Chem. 2019, 163, 443–452. PubMed
Bruno E., Buemi M. R., Di Fiore A., De Luca L., Ferro S., Angeli A., Cirilli R., Sadutto D., Alterio V., Monti S. M., Supuran C. T., De Simone G., Gitto R., J. Med. Chem. 2017, 60, 4316–4326. PubMed
Bruno E., Buemi M. R., De Luca L., Ferro S., Monforte A. M., Supuran C. T., Vullo D., De Sarro G., Russo E., Gitto R., ChemMedChem 2016, 11, 1812–1818. PubMed
Buemi M. R., De Luca L., Ferro S., Bruno E., Ceruso M., Supuran C. T., Pospisilova K., Brynda J., Rezacova P., Gitto R., Eur. J. Med. Chem. 2015, 102, 223–232. PubMed
De Luca L., Ferro S., Damiano F. M., Supuran C. T., Vullo D., Chimirri A., Gitto R., Eur. J. Med. Chem. 2014, 71, 105–111. PubMed
Gitto R., Damiano F. M., Mader P., De Luca L., Ferro S., Supuran C. T., Vullo D., Brynda J., Rezacova P., Chimirri A., J. Med. Chem. 2012, 55, 3891–3899. PubMed
Mader P., Brynda J., Gitto R., Agnello S., Pachl P., Supuran C. T., Chimirri A., Řezáčová P., J. Med. Chem. 2011, 54, 2522–2526. PubMed
Gitto R., Agnello S., Ferro S., De Luca L., Vullo D., Brynda J., Mader P., Supuran C. T., Chimirri A., J. Med. Chem. 2010, 53, 2401–2408. PubMed
Gitto R., De Luca L., Mancuso F., Del Prete S., Vullo D., Supuran C. T., Capasso C., J. Enzyme Inhib. Med. Chem. 2019, 34, 1186–1192. PubMed PMC
Capasso C., Supuran C. T., J. Enzyme Inhib. Med. Chem. 2015, 30, 325–332. PubMed
Supuran C. T., Nat. Rev. Drug Discovery 2008, 7, 168–181. PubMed
Scozzafava A., Briganti F., Mincione G., Menabuoni L., Mincione F., Supuran C. T., J. Med. Chem. 1999, 42, 3690–3700. PubMed
Chavez F., Kennedy N., Rawalpally T., Williamson R. T., Cleary T., Org. Process Res. Dev. 2010, 14, 579–584.
Abdel Gawad N. M., Amin N. H., Elsaadi M. T., Mohamed F. M. M., Angeli A., De Luca V., Capasso C., Supuran C. T., Bioorg. Med. Chem. 2016, 24, 3043–3051. PubMed
Kaur S. U., Oyeyemi B. F., Shet A., Gopalan B. P., Bhavesh H. D. N. S., Tandon R., PLoS One 2020, 15, e0238316. PubMed PMC
Rodriguez-Docampo Z., Quigley C., Tallon S., Connon S. J., J. Org. Chem. 2012, 77, 2407–2414. PubMed
Coban G., Kose F. A., Kirmizibayrak P. B., Pabuccuoglu V., Med. Chem. Res. 2015, 24, 3710–3729.
TuGrak M., Hi G. U., Anil B., Turk. J. Chem. 2020, 44, 1601–1609. PubMed PMC
Yun W., Ahmad M., Chen Y., Gillespie P., Conde-Knape K., Kazmer S., Li S., Qian Y., Taub R., Wertheimer S. J., Whittard T., Bolin D., Bioorg. Med. Chem. Lett. 2011, 21, 7205–7209. PubMed
De Luca V., Del Prete S., Supuran C. T., Capasso C., J. Enzyme Inhib. Med. Chem. 2015, 30, 277–282. PubMed
Khalifah R. G., J. Biol. Chem. 1971, 246, 2561–2573. PubMed
Del Prete S., Vullo D., De Luca V., Carginale V., di Fonzo P., Osman S. M., AlOthman Z., Supuran C. T., Capasso C., Bioorg. Med. Chem. 2016, 24, 4410–4414. PubMed
De Luca V., Vullo D., Del Prete S., Carginale V., Osman S. M., AlOthman Z., Supuran C. T., Capasso C., Bioorg. Med. Chem. 2016, 24, 835–840. PubMed